000 | 01413 a2200397 4500 | ||
---|---|---|---|
005 | 20250511181142.0 | ||
264 | 0 | _c19920702 | |
008 | 199207s 0 0 eng d | ||
022 | _a0941-0198 | ||
024 | 7 |
_a10.1007/BF00207615 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWillich, S N | |
245 | 0 | 0 |
_aPathophysiology and triggers of acute myocardial infarction: clinical implications. _h[electronic resource] |
260 |
_bThe Clinical investigator _c1992 |
||
300 |
_aS73-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
650 | 0 | 4 |
_aArousal _xdrug effects |
650 | 0 | 4 |
_aCarbazoles _xtherapeutic use |
650 | 0 | 4 | _aCarvedilol |
650 | 0 | 4 |
_aCircadian Rhythm _xdrug effects |
650 | 0 | 4 |
_aCoronary Artery Disease _xphysiopathology |
650 | 0 | 4 |
_aCoronary Circulation _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMyocardial Infarction _xphysiopathology |
650 | 0 | 4 |
_aPropanolamines _xtherapeutic use |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aVasodilator Agents _xtherapeutic use |
700 | 1 | _aJimenez, A H | |
700 | 1 | _aTofler, G H | |
700 | 1 | _aDeSilva, R A | |
700 | 1 | _aMuller, J E | |
773 | 0 |
_tThe Clinical investigator _gvol. 70 Suppl 1 _gp. S73-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00207615 _zAvailable from publisher's website |
999 |
_c1356990 _d1356990 |